PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells

被引:0
|
作者
Kotob, Shadi N. [1 ]
Kelts, Jessica L. [1 ]
机构
[1] Univ Michigan Flint, Dept Nat Sci, Flint, MI 48502 USA
来源
ACS OMEGA | 2023年 / 8卷 / 33期
关键词
MUTANT P53; TUMOR-GROWTH; D-RECEPTOR; IN-VIVO; APR-246; INHIBITION; APOPTOSIS; CALCIUM; EB1089; RISK;
D O I
10.1021/acsomega.3c03719
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Vitamin D is a steroidhormone that causes growth suppression incultured cells. We had previously discovered that the triple-negativebreast cancer cell lines MDA-MB-231 and MDA-MB-468 did not have growthsuppression with vitamin D, while MCF-7 did. MCF-7 cells are not triple-negativeand have wild-type p53. Both MDA-MB-231 and MDA-MB-468 have mutationsin p53 and these mutations were a possible explanation for the lackof growth suppression with vitamin D. Our hypothesis was that reactivationof p53 in the triple-negative cell lines would cause them to becomesensitive to vitamin D. We chose to use the small molecule PRIMA-1(MET) to reactivate p53 as it has been previously shown to restorefunction to the p53 mutants present in MB-231 and MB-468. We thenmeasured the ability of vitamin D and its analogues calcipotriol andEB1089 to suppress growth in the presence of PRIMA-1(MET). Here, we show that while PRIMA-1(MET) can kill the breastcancer cells investigated in this study, it does not restore theirsensitivity to vitamin D or its analogues.
引用
收藏
页码:30500 / 30507
页数:8
相关论文
共 50 条
  • [21] Epoxyazadiradione induced apoptosis/anoikis in triple-negative breast cancer cells, MDA-MB-231, by modulating diverse cellular effects
    Lakshmi, Sreerenjini
    Renjitha, Jalaja
    B. Sasidhar, Somappa
    Priya, Sulochana
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (06) : 1 - 17
  • [22] Enhanced Apoptotic Effects in MDA-MB-231 Triple-Negative Breast Cancer Cells Through a Synergistic Action of Luteolin and Paclitaxel
    Tamanna, Shabnam
    Perumal, Elumalai
    Rajanathadurai, Jeevitha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [23] Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells
    Hu, Ming-Bai
    Zhang, Jing-Wei
    Gao, Jing-Bo
    Qi, Yu-Wen
    Gao, Yang
    Xu, Liu
    Ma, Yanbing
    Wei, Zheng-Zhuan
    ULTRASTRUCTURAL PATHOLOGY, 2018, 42 (05) : 409 - 415
  • [24] Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA-MB-231 cells
    Huang, Ying
    Huang, Hui
    Wang, Shiying
    Chen, Feixiang
    Zheng, Gang
    MOLECULAR MEDICINE REPORTS, 2020, 22 (01) : 43 - 50
  • [25] Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
    Yiwei Li
    Sunil Upadhyay
    Mahbubur Bhuiyan
    Fazlul H Sarkar
    Oncogene, 1999, 18 : 3166 - 3172
  • [26] Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
    Li, YW
    Upadhyay, S
    Bhuiyan, M
    Sarkar, FH
    ONCOGENE, 1999, 18 (20) : 3166 - 3172
  • [27] The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells
    Luo, Can
    Wang, Yu
    Wei, Cheng
    Chen, Yuxin
    Ji, Zhaoning
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (01) : 273 - 279
  • [28] Selective Antiproliferative and Apoptotic Effects of 2,6-Diketopiperazines on MDA-MB-231 Triple-Negative Breast Cancer
    Gonzalez, Flor Paulina Garrido
    Perez, Martha Edith Macias
    Cortes, Octavio Rodriguez
    Jimenez, Elvia Mera
    Percino, Teresa Mancilla
    CHEMICAL BIOLOGY & DRUG DESIGN, 2025, 105 (04)
  • [29] Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel
    Simu, Sebastian
    Marcovici, Iasmina
    Dobrescu, Amadeus
    Malita, Daniel
    Dehelean, Cristina Adriana
    Coricovac, Dorina
    Olaru, Flavius
    Draghici, George Andrei
    Navolan, Dan
    MOLECULES, 2021, 26 (09):
  • [30] Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells
    Hong, Yinan
    Fan, Daidi
    TOXICOLOGY, 2019, 418 : 22 - 31